Payment overview · 2025
General Payments
$94.47
5 reported records · 1 companies
Healthcare provider profile · identity verified
Eugene W Williams, DO
Allopathic & Osteopathic Physicians|Family Medicine · EAST POINT, GA · NPI 1366551384
Verified facts
What the public records show
CMS Open Payments records show Eugene W Williams, DO received $94.47 in general payments during 2025 across 5 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$94.47 | 100.0% | 5 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $94.47 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $94.47 | 5 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 782 | 308 |
| Atorvastatin Calcium | Atorvastatin Calcium | 715 | 291 |
| Lisinopril | Lisinopril | 404 | 157 |
| Hydrochlorothiazide | Hydrochlorothiazide | 354 | 139 |
| Losartan Potassium | Losartan Potassium | 331 | 136 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 321 | 104 |
| Gabapentin | Gabapentin | 266 | 114 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 260 | 103 |
| Metformin Hcl | Metformin Hcl | 247 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 227 | 90 |
| Ozempic | Semaglutide | 203 | 42 |
| Carvedilol | Carvedilol | 161 | 69 |
| Levothyroxine Sodium | Levothyroxine Sodium | 146 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 137 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 126 | 50 |
| Trulicity | Dulaglutide | 124 | 27 |
| Meloxicam | Meloxicam | 121 | 51 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 120 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 119 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 118 | 53 |
| Farxiga | Dapagliflozin Propanediol | 118 | 42 |
| Omeprazole | Omeprazole | 114 | 50 |
| Furosemide | Furosemide | 112 | 44 |
| Diclofenac Sodium | Diclofenac Sodium | 110 | 61 |
| Ibuprofen | Ibuprofen | 104 | 59 |
| Spironolactone | Spironolactone | 98 | 42 |
| Allopurinol | Allopurinol | 85 | 36 |
| Famotidine | Famotidine | 84 | 28 |
| Januvia | Sitagliptin Phosphate | 82 | 34 |
| Tresiba Flextouch U-100 | Insulin Degludec | 82 | 28 |
| Simvastatin | Simvastatin | 81 | 33 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 37 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 74 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 70 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 69 | 30 |
| Metformin Hcl Er | Metformin Hcl | 66 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 64 | 25 |
| Nifedipine Er | Nifedipine | 64 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 61 | 23 |
| Colchicine | Colchicine | 59 | 21 |
| Pregabalin | Pregabalin | 58 | 17 |
| Meclizine Hcl | Meclizine Hcl | 57 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 57 | 27 |
| Eliquis | Apixaban | 56 | 22 |
| Potassium Chloride | Potassium Chloride | 56 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 51 | 23 |
| Trazodone Hcl | Trazodone Hcl | 51 | 20 |
| Sertraline Hcl | Sertraline Hcl | 50 | 17 |
| Prednisone | Prednisone | 49 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 48 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 47 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 46 | 19 |
| Chlorthalidone | Chlorthalidone | 45 | 23 |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 22 |
| Ezetimibe | Ezetimibe | 43 | 16 |
| Baclofen | Baclofen | 42 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 42 | 16 |
| Novolog Flexpen | Insulin Aspart | 41 | 15 |
| Naproxen | Naproxen | 39 | 16 |
| Tramadol Hcl | Tramadol Hcl | 39 | 18 |
| Xarelto | Rivaroxaban | 36 | 15 |
| Alendronate Sodium | Alendronate Sodium | 35 | 14 |
| Methylprednisolone | Methylprednisolone | 35 | 33 |
| Glipizide Er | Glipizide | 34 | 16 |
| Torsemide | Torsemide | 33 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 33 | suppressed |
| Lidocaine | Lidocaine | 31 | 13 |
| Techlite Pen Needle | Pen Needle, Diabetic | 31 | 18 |
| Valsartan | Valsartan | 31 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 29 | 18 |
| Celecoxib | Celecoxib | 26 | suppressed |
| Glipizide | Glipizide | 26 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 26 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 25 | suppressed |
| Jardiance | Empagliflozin | 25 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 23 | 11 |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | 11 |
| Atenolol | Atenolol | 22 | suppressed |
| Finasteride | Finasteride | 22 | 11 |
| Glimepiride | Glimepiride | 22 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | 12 |
| Lovastatin | Lovastatin | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | 12 |
| Mirtazapine | Mirtazapine | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Victoza 3-Pak | Liraglutide | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 11 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $94.47 · 5 records | Medtronic, Inc. | MINIMED 780G | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error